Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential for prevention of dementia in Denmark
Kasper Jørgensen, T. Rune Nielsen, Ann Merrit Rikke Nielsen, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 10, pp. 4590-4598
Open Access | Times Cited: 13

Showing 13 citing articles:

Population attributable fractions of modifiable risk factors for dementia: a systematic review and meta-analysis
Blossom C. M. Stephan, Louie Cochrane, Aysegul Humeyra Kafadar, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 6, pp. e406-e421
Open Access | Times Cited: 12
Update on modifiable risk factors for Alzheimer's disease and related dementias
Methasit Jaisa-aad, Clara Muñoz‐Castro, Alberto Serrano‐Pozo
Current Opinion in Neurology (2024) Vol. 37, Iss. 2, pp. 166-181
Open Access | Times Cited: 10
Examining multimorbidity contributors to dementia over time
Matthias Klee, Sheila Markwardt, Miriam R. Elman, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
Proton pump inhibitors and dementia: A nationwide population‐based study
Nelsan Pourhadi, Janet Janbek, Christina Jensen‐Dahm, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 837-845
Open Access | Times Cited: 18
Increasing awareness for dementia risk reduction through a public awareness campaign in Denmark: A pre-post study
Dominique Paauw, Irene Heger, Jon Fiala Bjerre, et al.
Preventive Medicine (2024) Vol. 179, pp. 107848-107848
Open Access | Times Cited: 5
Monoclonal antibodies for treating early Alzheimer disease—a commentary on recent ‘positive’ trials
Ian Scott
Age and Ageing (2024) Vol. 53, Iss. 2
Closed Access | Times Cited: 5
Preventing dementia in Italy: Estimations of modifiable risk factors and public health implications
Federica Asta, Guido Bellomo, Benedetta Contoli, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100055-100055
Open Access
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Mariagnese Barbera, Divaka Perera, Anna Matton, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 11
Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison
Sung Hyun Son, Mark Speechley, Guangyong Zou, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access | Times Cited: 4
Diagnostic accuracy of BASIC-Q for detection of cognitive impairment in a primary care setting – a cross-validation study
Anne‐Britt Oxbøll, Kasper Jørgensen, T. Rune Nielsen, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison
Surim Son, Mark Speechley, Guangyong Zou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Data-driven care for patients with neurodegenerative disorders
Gunhild Waldemar
Nature Reviews Neurology (2023) Vol. 19, Iss. 8, pp. 447-448
Open Access | Times Cited: 4
Identifying modifiable factors and their joint effect on frailty: a large population-based prospective cohort study
Lingzhi Ma, Yi‐Jun Ge, Yi Zhang, et al.
GeroScience (2024)
Closed Access | Times Cited: 1
Page 1

Scroll to top